BACKGROUND AND PURPOSE: The aim of the current study was to investigate the role of arachidonic acid (AA) metabolism via cyclooxygenase (COX) in the endothelial dysfunction of penile arteries from pre-diabetic, obese Zucker rats (OZR). EXPERIMENTAL APPROACH: Penile arteries from OZR and from lean Zucker rats (LZR) were mounted in microvascular myographs to assess vascular function and COX expression was determined by immunohistochemistry. KEY RESULTS: Acetylcholine (ACh) and AA elicited relaxations that were impaired in arteries from OZR. Inhibition of both COX-1 and COX-2 reduced the relaxant effects of ACh and AA in LZR but not in OZR. Inhibitors of COX-1 and of the TXA(2)/PGH(2) (TP) receptor enhanced the relaxations induced by AA in both LZR and OZR, whereas COX-2 inhibition enhanced these responses only in OZR. TP receptor blockade did not restore ACh relaxant responses in arteries from OZR. Inhibition of COX-1 increased basal tension in OZR and this contraction was blunted by TP receptor blockade. The vasoconstrictor responses to noradrenaline were augmented by indomethacin and by COX-2 inhibition in LZR but not in OZR. Immunohistochemical staining showed that both COX-1 and COX-2 are expressed in the endothelium of penile arteries from both LZR and OZR. CONCLUSIONS AND IMPLICATIONS: Vasoactive prostanoids were formed via constitutively active COX-1 and COX-2 pathways in normal rat penile arteries. Under conditions of insulin resistance, the release and/or effects of vasodilator prostanoids were impaired, contributing to the blunted endothelium-dependent vasodilatation and to the enhanced vasoconstriction.
BACKGROUND AND PURPOSE: The aim of the current study was to investigate the role of arachidonic acid (AA) metabolism via cyclooxygenase (COX) in the endothelial dysfunction of penile arteries from pre-diabetic, obese Zucker rats (OZR). EXPERIMENTAL APPROACH: Penile arteries from OZR and from lean Zucker rats (LZR) were mounted in microvascular myographs to assess vascular function and COX expression was determined by immunohistochemistry. KEY RESULTS:Acetylcholine (ACh) and AA elicited relaxations that were impaired in arteries from OZR. Inhibition of both COX-1 and COX-2 reduced the relaxant effects of ACh and AA in LZR but not in OZR. Inhibitors of COX-1 and of the TXA(2)/PGH(2) (TP) receptor enhanced the relaxations induced by AA in both LZR and OZR, whereas COX-2 inhibition enhanced these responses only in OZR. TP receptor blockade did not restore ACh relaxant responses in arteries from OZR. Inhibition of COX-1 increased basal tension in OZR and this contraction was blunted by TP receptor blockade. The vasoconstrictor responses to noradrenaline were augmented by indomethacin and by COX-2 inhibition in LZR but not in OZR. Immunohistochemical staining showed that both COX-1 and COX-2 are expressed in the endothelium of penile arteries from both LZR and OZR. CONCLUSIONS AND IMPLICATIONS: Vasoactive prostanoids were formed via constitutively active COX-1 and COX-2 pathways in normal rat penile arteries. Under conditions of insulin resistance, the release and/or effects of vasodilator prostanoids were impaired, contributing to the blunted endothelium-dependent vasodilatation and to the enhanced vasoconstriction.
Authors: K Kuboki; Z Y Jiang; N Takahara; S W Ha; M Igarashi; T Yamauchi; E P Feener; T P Herbert; C J Rhodes; G L King Journal: Circulation Date: 2000-02-15 Impact factor: 29.690
Authors: Javier Angulo; Pedro Cuevas; Jose M La Fuente; Jose M Pomerol; Eduardo Ruiz-Castañé; Ana Puigvert; Sonia Gabancho; Argentina Fernández; Peter Ney; Iñigo Sáenz De Tejada Journal: Br J Pharmacol Date: 2002-05 Impact factor: 8.739
Authors: Javier Angulo; Pedro Cuevas; Argentina Fernández; Sonia Gabancho; Antonio Allona; Antonio Martín-Morales; Ignacio Moncada; Sebastián Videla; Iñigo Sáenz de Tejada Journal: Biochem Biophys Res Commun Date: 2003-12-26 Impact factor: 3.575
Authors: José L Ruiz Rubio; Medardo Hernández; Luis Rivera de los Arcos; A Cristina Martínez; Albino García-Sacristán; Dolores Prieto Journal: J Urol Date: 2004-02 Impact factor: 7.450
Authors: Syed R Baber; Hunter C Champion; Trinity J Bivalacqua; Albert L Hyman; Philip J Kadowitz Journal: Circulation Date: 2003-08-04 Impact factor: 29.690
Authors: A Sánchez; P Martínez; M Muñoz; S Benedito; A García-Sacristán; M Hernández; D Prieto Journal: Br J Pharmacol Date: 2014-12 Impact factor: 8.739
Authors: Ana Cristina Martínez; Medardo Hernández; Susana Novella; María Pilar Martínez; Rosa María Pagán; Carlos Hermenegildo; Albino García-Sacristán; Dolores Prieto; Sara Benedito Journal: PLoS One Date: 2014-09-12 Impact factor: 3.240
Authors: Lucia Russo; Harrison T Muturi; Hilda E Ghadieh; Alexander M Wisniewski; Eric E Morgan; Syed S Quadri; Gavin P Landesberg; Helmy M Siragy; Guillermo Vazquez; Rosario Scalia; Rajesh Gupta; Sonia M Najjar Journal: Mol Metab Date: 2018-01-31 Impact factor: 8.568